These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2875724)

  • 21. [Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized man].
    Yajima C; Sugai N; Inada Y
    Masui; 1985 Sep; 34(9):1245-51. PubMed ID: 2868137
    [No Abstract]   [Full Text] [Related]  

  • 22. Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure.
    Bencini AF; Scaf AH; Sohn YJ; Meistelman C; Lienhart A; Kersten UW; Schwarz S; Agoston S
    Anesth Analg; 1986 Mar; 65(3):245-51. PubMed ID: 2869722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacodynamics of vecuronium in the kidney transplant recipient and the patient with normal renal function].
    Takita K; Goda Y; Kawahigashi H; Okuyama A; Kubota M; Kemmotsu O
    Masui; 1993 Feb; 42(2):190-4. PubMed ID: 8094765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hepatic uptake of vecuronium bromide and its putative metabolites on their neuromuscular blocking actions in the cat.
    Bencini AF; Houwertjes MC; Agoston S
    Br J Anaesth; 1985 Aug; 57(8):789-95. PubMed ID: 2861840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized children.
    Meistelman C; Agoston S; Kersten UW; Saint-Maurice C; Bencini AF; Loose JP
    Anesth Analg; 1986 Dec; 65(12):1319-23. PubMed ID: 2877596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Atracurium: neuromuscular blockade in repeated administration].
    Kube D; Schuh FT
    Anaesthesist; 1985 Dec; 34(12):639-44. PubMed ID: 2869712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fade profiles during spontaneous offset of neuromuscular blockade: vecuronium and gallamine compared.
    Power SJ; Pearce AC; Jones RM
    Br J Anaesth; 1988 Apr; 60(5):486-90. PubMed ID: 2897861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure.
    Fahey MR; Morris RB; Miller RD; Nguyen TL; Upton RA
    Br J Anaesth; 1981 Oct; 53(10):1049-53. PubMed ID: 6117300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamics of vecuronium and pancuronium in cats with and without ligated renal pedicles.
    Booij LH; Vree TB; Van de Pol F; Crul JF
    Acta Anaesthesiol Belg; 1982; 33(3):157-65. PubMed ID: 6128859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.
    Rørvik K; Husby P; Gramstad L; Vamnes JS; Bitsch-Larsen L; Koller ME
    Br J Anaesth; 1988 Aug; 61(2):180-5. PubMed ID: 2901270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics of vecuronium administered by bolus and infusion during halothane or balanced anesthesia.
    Shanks CA; Avram MJ; Fragen RJ; O'Hara DA
    Clin Pharmacol Ther; 1987 Oct; 42(4):459-64. PubMed ID: 2889555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between the continuous infusion of vecuronium and the intermittent administration of pancuronium and vecuronium.
    Noeldge G; Hinsken H; Buzello W
    Br J Anaesth; 1984 May; 56(5):473-7. PubMed ID: 6144316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1986 Nov; 58(11):1285-9. PubMed ID: 2877681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromuscular block by vecuronium: simulation with a flow-volume model.
    Nigrovic V
    Eur J Anaesthesiol; 1994 Mar; 11(2):65-74. PubMed ID: 7909750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacodynamics and pharmacokinetics of vecuronium in patients anesthetized with isoflurane with normal renal function or with renal failure.
    Lynam DP; Cronnelly R; Castagnoli KP; Canfell PC; Caldwell J; Arden J; Miller RD
    Anesthesiology; 1988 Aug; 69(2):227-31. PubMed ID: 2900610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vecuronium and atracurium in patients with end-stage renal failure. A comparative study.
    Lepage JY; Malinge M; Cozian A; Pinaud M; Blanloeil Y; Souron R
    Br J Anaesth; 1987 Aug; 59(8):1004-10. PubMed ID: 2888474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vecuronium neuromuscular block in patients with malignant obstructive jaundice.
    Baraka A
    Can J Anaesth; 1994 Aug; 41(8):759-60. PubMed ID: 7923531
    [No Abstract]   [Full Text] [Related]  

  • 38. The neuromuscular blocking effect of vecuronium on the human diaphragm.
    Chauvin M; Lebrault C; Duvaldestin P
    Anesth Analg; 1987 Feb; 66(2):117-22. PubMed ID: 2880529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of vecuronium in rats with systemic inflammatory response syndrome: treatment with NG-monomethyl-L-arginine.
    Blobner M; Kochs E; Fink H; Mayer B; Veihelmann A; Brill T; Stadler J
    Anesthesiology; 1999 Oct; 91(4):999-1005. PubMed ID: 10519503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.